Skip to main content
. 2020 May 30;111(6):2174–2182. doi: 10.1111/cas.14425

TABLE 1.

Details of driver gene mutations in 50 patients with pancreatic ductal adenocarcinoma

Parameter KRAS (n = 42) TP53 (n = 31) SMAD4 (n = 16) CDKN2A (n = 9)
Mutation, n (%)
Missense 42 (100.0) 25 (80.6) 9 (56.3) 5 (55.6)
Nonsense 0 (0.0) 4 (12.9) 4 (25.0) 3 (33.3)
Frameshift insertion 0 (0.0) 1 (3.2) 2 (12.5) 0 (0.0)
Frameshift deletion 0 (0.0) 1 (3.2) 1 (6.3) 1 (11.1)
KRAS mutant subtype, n (%)
G12D 20 (47.6)
G12V 15 (35.7)
G12R 4 (9.5)
Q61H 3 (7.1)